Related Experiment Video
Updated: Aug 30, 2025

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Bacteriophage therapy for periprosthetic joint infections: Current limitations and research needed to advance this
James B Doub1, Ken Urish2, Benjamin Chan3,4
1Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Abstract:
Bacteriophage therapy is a promising treatment for periprosthetic joint infections (PJIs), particularly given these agents have innate abilities to degrade the biofilm matrix and lyse bacteria within. However, many aspects of this therapy are poorly understood causing treatments to lack uniform effectiveness and reproducibility, which is in part a consequence of several inherent limitations to using bacteriophages to treat PJI. Herein, these limitations are discussed as are additional translational research that needs to be conducted to advance this therapeutic. These include determining if bacteria causing PJIs are polyclonal, consequences of bacteriophage attachment receptor phenotypic variations and ramifications of bacteriophage activity when bacteria interact with in vivo macromolecules. Only with the realization of the current limitations and subsequent knowledge gained from translational research will the potential of bacteriophages to reduce the morbidity and mortality in PJI be fully elucidated.
Insights
Bacteriophage therapy shows promise for periprosthetic joint infections (PJIs) due to biofilm degradation and bacterial lysis. Further research is needed to overcome limitations and enhance the effectiveness of bacteriophages for PJI treatment.
Area of Science:
- Microbiology
- Infectious Diseases
- Biotechnology
Background:
- Periprosthetic joint infections (PJIs) are serious complications of joint replacement surgery.
- Bacteriophage therapy offers a potential alternative to antibiotics for treating PJIs, leveraging natural antimicrobial properties.
- Current understanding and application of bacteriophage therapy for PJIs remain limited, impacting treatment consistency.
Purpose of the Study:
- To discuss the limitations of bacteriophage therapy for PJIs.
- To identify critical areas for translational research to advance bacteriophage therapy for PJIs.
- To elucidate the potential of bacteriophages in reducing PJI-related morbidity and mortality.
Main Methods:
- Literature review and critical analysis of existing research on bacteriophage therapy for PJIs.
- Identification and discussion of inherent limitations in bacteriophage therapy for PJI treatment.
- Outline of essential translational research directions.
Main Results:
- Bacteriophages possess inherent capabilities to degrade biofilm matrices and lyse bacteria within biofilms.
- Significant knowledge gaps exist regarding bacteriophage therapy for PJIs, affecting treatment efficacy and reproducibility.
- Key research areas include bacterial polyclonal nature in PJIs, bacteriophage receptor variations, and interactions with host macromolecules.
Conclusions:
- Bacteriophage therapy holds significant potential for treating PJIs.
- Addressing identified limitations through targeted translational research is crucial for optimizing bacteriophage therapy.
- Further research will enable the full realization of bacteriophages' potential in managing PJI morbidity and mortality.
More Related Videos
Related Concept Videos
Lytic Cycle of Bacteriophages
Microorganisms in Medicine and Therapeutics
Acute Pyelonephritis II: Diagnostic Studies and Management
Gene Regulation in Microbial Communities: Quorum Sensing
DNA Bacteriophages
Endocarditis III: Medical Management

